169 related articles for article (PubMed ID: 22426760)
1. The influence of botulinum toxin on auditory disturbances in hemifacial spasm.
Rudzińska M; Wójcik M; Zajdel K; Hydzik-Sobocińska K; Malec M; Hartel M; Składzień J; Szczudlik A
Neurol Neurochir Pol; 2012; 46(1):29-36. PubMed ID: 22426760
[TBL] [Abstract][Full Text] [Related]
2. Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.
Rudzińska M; Wójcik M; Szczudlik A
J Neural Transm (Vienna); 2010 Jun; 117(6):765-72. PubMed ID: 20467763
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting the quality of life in hemifacial spasm patients.
Rudzińska M; Wójcik M; Malec M; Grabska N; Szubiga M; Hartel M; Szczudlik A
Neurol Neurochir Pol; 2012; 46(2):121-9. PubMed ID: 22581593
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm.
Pandey S; Jain S
Neurol India; 2018; 66(4):1036-1042. PubMed ID: 30038089
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A improves psychological distress in patients with hemifacial spasm.
Wang C; Zhu X; Xia L; Xie P; Tian X; Shang J; Han Q
Acta Neurol Belg; 2022 Feb; 122(1):43-49. PubMed ID: 33515182
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment.
Yuksel B; Genc F; Yaman A; Goksu EO; Ak PD; Gomceli YB
Acta Neurol Belg; 2019 Mar; 119(1):55-60. PubMed ID: 30178181
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.
Defazio G; Abbruzzese G; Girlanda P; Vacca L; Currà A; De Salvia R; Marchese R; Raineri R; Roselli F; Livrea P; Berardelli A
Arch Neurol; 2002 Mar; 59(3):418-20. PubMed ID: 11890846
[TBL] [Abstract][Full Text] [Related]
8. Treatment with botulinum toxin improves the hyperexcitability of the facial motoneuron in patients with hemifacial spasm.
Ishikawa M; Takashima K; Kamochi H; Kusaka G; Shinoda S; Watanabe E
Neurol Res; 2010 Jul; 32(6):656-60. PubMed ID: 19660185
[TBL] [Abstract][Full Text] [Related]
9. Headache in hemifacial spasm patients.
Peeraully T; Tan SF; Fook-Chong SM; Prakash KM; Tan EK
Acta Neurol Scand; 2013 May; 127(5):e24-7. PubMed ID: 23311349
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
11. Hemifacial spasm: clinical findings and treatment.
Wang A; Jankovic J
Muscle Nerve; 1998 Dec; 21(12):1740-7. PubMed ID: 9843077
[TBL] [Abstract][Full Text] [Related]
12. Hemifacial spasm through the last three decades: From etiology to efficacy and safety of long-term botulinum toxin treatment.
Herrero-Infante Y; Rodríguez-Sanz A; Máñez-Miró J; Vivancos-Matellano F
Clin Neurol Neurosurg; 2021 Apr; 203():106555. PubMed ID: 33662742
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience.
Barbosa ER; Takada LT; Gonçalves LR; Costa RM; Silveira-Moriyama L; Chien HF
Arq Neuropsiquiatr; 2010 Aug; 68(4):502-5. PubMed ID: 20730300
[TBL] [Abstract][Full Text] [Related]
14. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and treatment status of hemifacial spasm in China.
Wang L; Hu X; Dong H; Wang W; Huang Y; Jin L; Luo Y; Zhang W; Lian Y; Liang Z; Shang H; Feng Y; Wu Y; Chen J; Luo W; Wan X
Chin Med J (Engl); 2014; 127(5):845-9. PubMed ID: 24571874
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30).
Tan EK; Fook-Chong S; Lum SY; Lim E
J Neurol Sci; 2004 Apr; 219(1-2):151-5. PubMed ID: 15050451
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
18. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
Colakoglu BD; Cakmur R; Uzunel F
Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated.
Batisti JP; Kleinfelder AD; Galli NB; Moro A; Munhoz RP; Teive HA
Arq Neuropsiquiatr; 2017 Feb; 75(2):87-91. PubMed ID: 28226076
[TBL] [Abstract][Full Text] [Related]
20. Influence of involuntary eyelid spasms on corneal topographic and eyelid morphometric changes in patients with hemifacial spasm.
Osaki T; Osaki MH; Osaki TH; Hirai FE; Nallasamy N; Campos M
Br J Ophthalmol; 2016 Jul; 100(7):963-970. PubMed ID: 26541432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]